Anti-E2F8抗体
Anti-E2F8 antibody
Be the first to review this product! Submit a review
|
(13 Publications)
Rabbit Polyclonal E2F8 antibody. Suitable for IP, WB and reacts with Human, Mouse samples. Cited in 13 publications. Immunogen corresponding to Synthetic Peptide within Human Transcription factor E2F8 aa 800 to C-terminus.
查看别名
Transcription factor E2F8, E2F-8, E2F8
- IP
Unknown
Immunoprecipitation - Anti-E2F8 antibody (AB109596)
Detection of E2F8 by Western Blot of Immunprecipitate.
ab109596 at 0.1 μg/mL staining E2F8 in Jurkat whole cell lysate immunoprecipitated using ab109596 at 6μg/mg lysate (1 mg/IP; 20% of IP loaded/lane). Detection : Chemiluminescence with exposure time of 3 seconds
All lanes:
Immunoprecipitation - Anti-E2F8 antibody (ab109596)
Predicted band size: 94 kDa
false
- WB
Unknown
Western blot - Anti-E2F8 antibody (AB109596)
All lanes:
Western blot - Anti-E2F8 antibody (ab109596) at 0.1 µg/mL
Lane 1:
293T whole cell lysate at 50 µg
Lane 2:
293T whole cell lysate at 15 µg
Lane 3:
293T whole cell lysate at 5 µg
Lane 4:
HeLa whole cell lysate at 50 µg
Lane 5:
NIH3T3 whole cell lysate at 50 µg
Predicted band size: 94 kDa
true
Exposure time: 3min
- WB
CiteAb
Western blot - Anti-E2F8 antibody (AB109596)
E2F8 western blot using anti-E2F8 antibody ab109596. Publication image and figure legend from Weijts, B. G., van Impel, A., et al., 2013, PLoS One, PubMed 24069224.
ab109596 was used in this publication in western blot. This may not be the same as the application(s) guaranteed by Abcam. For a full list of applications guaranteed by Abcam for ab109596 please see the product overview.
E2F7/8 directly regulate CCBE1 and FLT4 expression.A, Genes associated with the gene ontology (GO) term angiogenesis were extracted from the Sox2-cre;E2f7loxP/-E2f8loxP/- vs. wild-type E10.5 mouse embryos (p<0.05) database (GEO : GSE30488) and additionally analyzed for E2F binding sites and their presence in GO lymphangiogenesis (GO : 0001946). B, E2F binding elements within the CCBE1 and FLT4 promoter. Average and canonical E2F binding consensus. C, E2F7 and E2F8 ChIP performed on CCBE1 and FLT4 promoters in HeLa cells, arrows in (B) indicate primers used for ChIP. A previous reported E2F site within the E2F1 promoter and a non-specific site upstream (+700 bp) served as controls. D, mRNA and protein levels of E2f7-EGFP inducible HeLa cells treated with doxycyclin (0.2 μg /ml) for 24 hours. E, mRNA and protein levels of HeLa cells treated with scrambled or E2f7/8 siRNAs. Fold change in protein were calculated using TUBULIN as reference. Data presented as the average (±s.e.m.) compared to the control condition in three independent experiments.
false
反应性数据
性能和储存信息
形式
纯化工艺
存储溶液
运输条件
推荐的短期储存条件
推荐的长期储存条件
分装信息
储存信息
补充信息
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
E2F8 acts as a regulator within the context of the cell cycle. It forms a complex with other E2F family members such as E2F7 which can bind to specific DNA sequences and regulate the transcription of genes necessary for the G1/S transition. This activity makes E2F8 essential for controlling cell growth and maintaining cellular homeostasis. E2F8's ability to act as a repressor distinguishes it from other E2Fs which typically activate transcription.
Pathways
E2F8 integrates into the mechanistic framework of the cell cycle and DNA repair pathways. Its activity is closely tied to the p53 pathway where it can influence p53-mediated transcriptional repression. E2F8 influences other family proteins like E2F1 which are important in driving cell cycle progression and apoptosis. By modulating these pathways E2F8 fine-tunes the balance between cell division and cell death—an important aspect of normal development and tumor suppression.
产品实验方案
- Visit the General protocols
- Visit the Troubleshooting
靶点信息
文献 (13)
Recent publications for all applications. Explore the full list and refine your search
Molecules and cells 47:100148 PubMed39537030
2024
Applications
Unspecified application
Species
Unspecified reactive species
Nature communications 13:6069 PubMed36241625
2022
Applications
Unspecified application
Species
Unspecified reactive species
Cell death & disease 13:230 PubMed35279688
2022
Applications
Unspecified application
Species
Unspecified reactive species
Journal of cellular physiology 236:4050-4065 PubMed33174204
2020
Applications
Unspecified application
Species
Unspecified reactive species
Frontiers in oncology 10:561287 PubMed33224876
2020
Applications
Unspecified application
Species
Unspecified reactive species
Scientific reports 10:4077 PubMed32139766
2020
Applications
Unspecified application
Species
Unspecified reactive species
Journal of translational medicine 17:427 PubMed31878977
2019
Applications
Unspecified application
Species
Unspecified reactive species
Oncotarget 8:101509-101519 PubMed29254182
2017
Applications
Unspecified application
Species
Unspecified reactive species
The Journal of clinical investigation 126:2955-69 PubMed27454291
2016
Applications
Unspecified application
Species
Unspecified reactive species
Human molecular genetics 25:2789-2800 PubMed27149985
2016
Applications
Unspecified application
Species
Unspecified reactive species
Abcam Product Promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com